Search for Clinical Trial Results
Essential Thrombocythemia - 25 Studies Found
Status | Study |
Completed |
Study Name: Exploratory Multi-centre Trial In Patients With ET Treated With XAGRID® Condition: Essential Thrombocythaemia Date: 2011-05-10 Interventions: Drug: Anagrelide hydrochloride 0.5 mg hard capsules, dosing decisions will be made by the treating physi |
Recruiting |
Study Name: Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET Genes Condition:
Interventions: Drug: CYT387 For the Part 1 dose-escalation portion of the |
Completed |
Study Name: Extension Study Evaluating the Long Term Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET) Condition:
Interventions: Drug: Momelotinib Patients will continue receiving the same doses as assigned during the CCL09101 protoc |
Not yet recruiting |
Study Name: 18F-FLT (PET/CT) in Prefibrotic/Early Primary Myelofibrosis and Essential Thrombocythemia Condition:
|